Engineered Microbes for Producing Anticholinergics

被引:1
作者
Courdavault, Vincent [1 ]
Cassereau, Julien [2 ]
Papon, Nicolas [3 ,4 ]
机构
[1] Univ Tours, Fac Pharm, EA2106 BBV, 31 Ave Monge, F-37200 Tours, France
[2] Univ Angers, MitoVasc Inst, INSERM 1083, MitoLab,CNRS,UMR 6015, Angers, France
[3] Univ Brest, Univ Angers, Host Pathogen Interact Study Grp GEIHP, EA 3142, Angers, France
[4] Univ Angers, Federat Struct Res Cellular Interact & Therapeut, SFR 4208 ICAT, Angers, France
关键词
anticholinergics; bioproduction; hyoscyamine dehydrogenase; tropane alkaloids; yeast;
D O I
10.1002/cbic.202000757
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tropane alkaloids (TAs) hyoscyamine and scopolamine function as acetylcholine receptor antagonists and are used clinically as parasympatholytics to treat neuromuscular disorders in humans. While TAs are synthesized in a small subset of plant families, these specialized metabolites are only accumulated in limited quantities in plant organs. The complex chemical structures of these compounds make their industrial production by chemical synthesis very challenging, Therefore, the supply of these TAs still relies on intensive farming of Duboisia shrubs in tropical countries. Many adverse factors such as climate fluctuations and pandemics can thus influence annual world production. Based on the landmark microbial production of the antimalarial semi-synthetic artemisinin, the Smolke group recently developed a yeast cell factory capable of de novo synthesizing hyoscyamine and scopolamine, thus paving the way for an alternative production of these compounds.
引用
收藏
页码:1368 / 1370
页数:3
相关论文
共 50 条
  • [21] Impact of Antipsychotics and Anticholinergics on Autonomic Modulation in Patients With Schizophrenia
    Huang, Wei-Lieh
    Chang, Li-Ren
    Kuo, Terry B. J.
    Lin, Yu-Hsuan
    Chen, Ying-Zai
    Yang, Cheryl C. H.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2013, 33 (02) : 170 - 177
  • [22] Effect of Desmopressin with Anticholinergics in Female Patients with Overactive Bladder
    Han, Young Kook
    Lee, Won Ki
    Lee, Seong Ho
    Yang, Dae Yul
    Kim, Hayoung
    KOREAN JOURNAL OF UROLOGY, 2011, 52 (06) : 396 - 400
  • [23] Impact of treatment of overactive bladder with anticholinergics on sexual function
    Swati Jha
    Archives of Gynecology and Obstetrics, 2016, 293 : 403 - 406
  • [24] Does gabapentin impact response to anticholinergics for overactive bladder?
    Roberts, Kasey
    Dao, Angela
    Alfahmy, Anood
    Mitchell, Diana
    Sheyn, David
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2022, 33 (09) : 2501 - 2506
  • [25] The role of anticholinergics in the treatment of Parkinson's disease.
    Danielczyk, W
    Schnaberth, G
    NEUROPSYCHIATRIE, 1995, 9 : S25 - S26
  • [26] Concomitant Use of Cholinesterase Inhibitors and Anticholinergics: Prevalence and Outcomes
    Boudreau, Denise M.
    Yu, Onchee
    Gray, Shelly L.
    Raebel, Marsha A.
    Johnson, Jeanene
    Larson, Eric B.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2011, 59 (11) : 2069 - 2076
  • [27] Anticholinergics for treatment of chronic obstructive pulmonary disease (COPD)
    Beeh, KM
    Welte, T
    Buhl, R
    MEDIZINISCHE KLINIK, 2000, 95 (10) : 552 - 558
  • [28] Impact of treatment of overactive bladder with anticholinergics on sexual function
    Jha, Swati
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2016, 293 (02) : 403 - 406
  • [29] An overlooked effect of systemic anticholinergics: alteration on accommodation amplitude
    Sekeroglu, Mehmet Ali
    Hekimoglu, Emre
    Anayol, Mustafa Alpaslan
    Tasci, Yasemin
    Dolen, Ismail
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2016, 9 (05) : 743 - 745
  • [30] Effects of selected anticholinergics on acoustic startle response in rats
    Sipos, ML
    Burchnell, V
    Galbicka, G
    JOURNAL OF APPLIED TOXICOLOGY, 2001, 21 : S95 - S101